rubella serology
Recently Published Documents


TOTAL DOCUMENTS

18
(FIVE YEARS 1)

H-INDEX

4
(FIVE YEARS 0)

2021 ◽  
Vol 26 (20) ◽  
Author(s):  
Sofie Colman ◽  
Kris Vernelen ◽  
Bernard China ◽  
Dorien Van den Bossche ◽  
Laura Cornelissen ◽  
...  

Background In Belgium, rubella serology is frequently requested in women of childbearing age, despite high vaccination coverage and a near-absence of congenital rubella cases. Different test kits are available and should be standardised by an international standard preparation. Aim To analyse and compare rubella serology practices in Belgian laboratories. Methods As part of the mandatory External Quality Assessment programme for rubella serology in Belgium, the national public health institute, Sciensano, sent a voluntary questionnaire concerning anti-rubella IgM/IgG analyses in women aged 15 to 45 years in 2017 to 130 laboratories. Results The questionnaire response rate was 83.8% (109/130). The majority of 169,494 IgG analyses were performed on Roche (55%), Abbott (17%) and Diasorin (13%) analysers. Not all laboratories used the proposed international cut-off of 10 IU/mL. Assumed median seroprevalence ranged from 76.3% with Liaison (Diasorin) to 96.3% with Modular (Roche). Despite very low rubella incidence in Belgium, 93 laboratories performed 85,957 IgM analyses, with 748 positive and 394 grey zone results. The National Reference Centre for Measles, Mumps and Rubella virus and the National Reference Centre for Congenital infections did not confirm any positive rubella cases in 2017. Conclusion This retrospective analysis shows that rubella serology results may differ considerably according to the assay used. It is therefore important to use the same test when comparing results or performing follow-up testing. The number of anti-rubella IgM analyses was very high. Incorrect use of IgM for screening women of childbearing age can lead to unwarranted anxiety and overuse of confirmation tests.


2020 ◽  
Vol 7 (10) ◽  
pp. 2054
Author(s):  
Mahmoud M. Osman ◽  
Meryat T. Zakaria ◽  
Mutassem F. Alnofal ◽  
Sulafa A. Hamdoun ◽  
Mohammed S. Alissa

Currently, rubella virus infections are very rare in many countries, and may not be recognized promptly.  However, congenital rubella syndrome still appears, often in infants of mothers coming from countries with suboptimal vaccination programs. We describe a case of CRS in a full-term baby girl born to a foreign mother who documented perinatal antibodies against rubella. The baby had the classical abnormalities seen in infants with CRS include congenital cardiac and ocular anomalies. The diagnosis was confirmed by positive rubella serology in both infant and mother. Vaccination is the only known prophylactic measure for congenital rubella syndrome.


2019 ◽  
Vol 11 (4) ◽  
Author(s):  
Makoura Barro ◽  
Yahaya S. Ouedraogo ◽  
Fatimata S. Nacro ◽  
Bintou Sanogo ◽  
Solange O. Kombasséré ◽  
...  

Apert syndrome or acrocephalosyndactyly is a rare genetic disease characterized by craniofacial dysmorphism and syndactyly of the hands and feet. We report an observation in a 4-month-old female infant, whose father was 65 years old. The infant was admitted to the neonatology of Sourô Sanou University Hospital (Burkina Faso) for respiratory distress in a congenital malformation disorders context with the notion of resuscitation for 10 minutes at birth. Her clinical examination revealed a craniofacial dysmorphism, syndactyly, choanal atresia, a cleft palate and a retardation of the psychomotor development. The paraclinical assessment consisted of a radiograph of the skeleton and a cerebral tomodensitometry confirming bicoronal synostosis and bone syndactyly; an abdominopelvic, cardiac ultrasound didn’t reveal any abnormalities; toxoplasmic serology was negative and rubella serology positive. The association of Apert syndrome with positive rubella serology seems fortuitous. Also, the association of choanal atresia and cleft palate has not commonly been reported in Apert syndrome. In the absence of surgical the infant has been followed until 9 months with therapeutic prospects.


Risk Analysis ◽  
2015 ◽  
Vol 36 (7) ◽  
pp. 1459-1486 ◽  
Author(s):  
Kimberly M. Thompson ◽  
Cassie L. Odahowski

2008 ◽  
Vol 6 (S1) ◽  
Author(s):  
MW Heijstek ◽  
GAM Berbers ◽  
PGM van Gageldonk ◽  
CSP Uiterwaal ◽  
NM Wulffraat

1998 ◽  
Vol 91 (9) ◽  
pp. 842-846
Author(s):  
MARTIN E. OLSEN ◽  
NATALIE M. OLSEN ◽  
KEVIN BREUEL ◽  
CAROL BURHENN ◽  
JOHN H. KALBFLEISCH

1998 ◽  
Vol 91 (2) ◽  
pp. 159-160 ◽  
Author(s):  
CHRISTINA GLICK ◽  
SANDOR FELDMAN ◽  
MITZI R. NORRIS ◽  
JOIS BUTLER

1985 ◽  
Vol 4 (4) ◽  
pp. 424
Author(s):  
Ernest P. Mennillo ◽  
James D. Cherry
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document